Insider Transactions in Q2 2023 at Castle Biosciences Inc (CSTL)
Insider Transaction List (Q2 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 05
2023
|
Ellen Goldberg Director |
BUY
Open market or private purchase
|
Direct |
4,800
+23.78%
|
$67,200
$14.25 P/Share
|
Jun 02
2023
|
Kim Caple Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,825
+47.28%
|
-
|
Jun 02
2023
|
G Bradley Cole Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,825
+45.11%
|
-
|
Jun 02
2023
|
Mara G. Aspinall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,825
+9.73%
|
-
|
Jun 02
2023
|
Daniel Bradbury Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,825
+45.11%
|
-
|
Jun 02
2023
|
Miles Harrison Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,825
+45.11%
|
-
|
Jun 02
2023
|
Ellen Goldberg Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,825
+47.28%
|
-
|
Jun 02
2023
|
Tiffany Olson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,825
+34.44%
|
-
|
May 16
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
2,506
-1.25%
|
$55,132
$22.82 P/Share
|
May 16
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
1,254
-0.83%
|
$27,588
$22.82 P/Share
|
May 15
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
3,074
-1.5%
|
$70,702
$23.45 P/Share
|
May 15
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
1,538
-1.01%
|
$35,374
$23.45 P/Share
|
May 10
2023
|
Tiffany Olson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
487
+12.35%
|
-
|
May 05
2023
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
7,357
-1.14%
|
$154,497
$21.46 P/Share
|
May 04
2023
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
17,643
-2.59%
|
$370,503
$21.59 P/Share
|
May 04
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
5,580
-1.33%
|
$117,180
$21.69 P/Share
|
May 04
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
2,792
-0.91%
|
$58,632
$21.69 P/Share
|
Apr 13
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
3,644
-1.7%
|
$80,168
$22.68 P/Share
|
Apr 13
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
1,823
-1.16%
|
$40,106
$22.68 P/Share
|
Apr 12
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
1,936
-0.89%
|
$42,592
$22.61 P/Share
|
Apr 12
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
969
-0.62%
|
$21,318
$22.61 P/Share
|
Apr 05
2023
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
7,100
-2.02%
|
$156,200
$22.2 P/Share
|
Apr 04
2023
|
Frank Stokes Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+14.59%
|
$12,000
$3.38 P/Share
|
Apr 04
2023
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
7,600
-2.11%
|
$167,200
$22.19 P/Share
|
Apr 04
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
801
-0.37%
|
$17,622
$22.1 P/Share
|
Apr 04
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
401
-0.25%
|
$8,822
$22.1 P/Share
|
Apr 03
2023
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
10,300
-2.78%
|
$226,600
$22.14 P/Share
|
Apr 03
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect |
4,779
-2.14%
|
$105,138
$22.15 P/Share
|
Apr 03
2023
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
2,391
-1.49%
|
$52,602
$22.15 P/Share
|